Nepsis Inc. Purchases 3,394 Shares of The Cigna Group (NYSE:CI)

Nepsis Inc. increased its holdings in The Cigna Group (NYSE:CI - Free Report) by 7.4% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 49,435 shares of the health services provider's stock after buying an additional 3,394 shares during the period. The Cigna Group accounts for approximately 4.1% of Nepsis Inc.'s portfolio, making the stock its 14th largest holding. Nepsis Inc.'s holdings in The Cigna Group were worth $17,126,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. Cedar Wealth Management LLC bought a new position in shares of The Cigna Group in the 1st quarter worth $29,000. TruNorth Capital Management LLC purchased a new stake in The Cigna Group during the second quarter valued at about $33,000. Ulland Investment Advisors LLC raised its position in The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider's stock valued at $36,000 after purchasing an additional 100 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of The Cigna Group in the 2nd quarter worth about $66,000. Finally, Private Ocean LLC increased its position in shares of The Cigna Group by 29.9% during the 2nd quarter. Private Ocean LLC now owns 200 shares of the health services provider's stock valued at $66,000 after purchasing an additional 46 shares during the last quarter. Institutional investors own 86.99% of the company's stock.

The Cigna Group Trading Down 4.8 %

Shares of NYSE:CI traded down $17.12 on Friday, hitting $336.00. The company had a trading volume of 2,712,344 shares, compared to its average volume of 1,480,892. The firm's 50-day simple moving average is $350.66 and its two-hundred day simple moving average is $344.17. The firm has a market capitalization of $95.45 billion, a price-to-earnings ratio of 27.59, a P/E/G ratio of 1.05 and a beta of 0.50. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.73. The Cigna Group has a 1 year low of $253.95 and a 1 year high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The health services provider reported $6.72 EPS for the quarter, topping the consensus estimate of $6.42 by $0.30. The Cigna Group had a net margin of 1.70% and a return on equity of 17.83%. The business had revenue of $60.52 billion during the quarter, compared to analyst estimates of $58.30 billion. During the same period last year, the business posted $6.13 earnings per share. The Cigna Group's quarterly revenue was up 24.6% compared to the same quarter last year. Equities analysts anticipate that The Cigna Group will post 28.48 earnings per share for the current fiscal year.

The Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 19th. Shareholders of record on Wednesday, September 4th were issued a $1.40 dividend. The ex-dividend date of this dividend was Wednesday, September 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.67%. The Cigna Group's dividend payout ratio (DPR) is 45.98%.

Insider Buying and Selling at The Cigna Group

In other news, Director William J. Delaney III sold 2,691 shares of the company's stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the sale, the director now directly owns 17,539 shares of the company's stock, valued at $6,010,264.52. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.60% of the company's stock.

Analysts Set New Price Targets

CI has been the subject of a number of recent research reports. Royal Bank of Canada restated an "outperform" rating and issued a $384.00 target price on shares of The Cigna Group in a research report on Monday, September 9th. Stephens reaffirmed an "overweight" rating and issued a $410.00 price objective on shares of The Cigna Group in a research note on Friday, August 2nd. JPMorgan Chase & Co. lifted their target price on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 21st. StockNews.com upgraded shares of The Cigna Group from a "buy" rating to a "strong-buy" rating in a research report on Friday, August 2nd. Finally, Jefferies Financial Group raised their price objective on The Cigna Group from $402.00 to $422.00 and gave the company a "buy" rating in a research note on Tuesday, September 17th. One analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $392.79.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.